Featured Research

from universities, journals, and other organizations

Possible New Approach To Brain Tumors In AIDS Patients

Date:
September 1, 1997
Source:
Ohio State University
Summary:
Researchers may be close to developing an additional weapon for treating a type of rapidly growing, fatal brain tumor that often afflicts AIDS patients.

COLUMBUS, Ohio -- Researchers may be close to developing an additional weapon for treating atype of rapidly growing, fatal brain tumor that often afflicts AIDS patients.

The new approach, reported in the latest issue of the journal Blood, focuses on activating a proteinreceptor that stimulates cells to commit suicide.

These specific tumors -- primary central nervous system lymphomas (PCNSL) -- have now beenshown by the researchers to express the receptor (called FAS) and to undergo cell death when thatreceptor is triggered.

Since the brain itself does not appear to express this receptor, researchers may be able to trigger thereceptor on the tumor cells without damaging nearby normal brain tissue. These lymphomas are nowalmost universally untreatable and can kill a patient within two to four months after the condition isdiagnosed.

These brain tumors almost always contain Epstein-Barr virus, a virus that normally remains dormant inmost normal people, held at bay by healthy lymphocytes called T-cells. But when the immune system isdamaged, or the number of T-cells has dropped substantially -- as is the case with AIDS patients -- thevirus activates, presumably leading to the brain lymphoma.

Robert Baiocchi, a third-year medical student at Ohio State University, and Michael Caligiuri,co-director of the division of hematology and oncology and associate director for clinical cancerresearch for the university’s Comprehensive Cancer Center, led the work.

They examined tissue taken from eight different AIDS patients who had died from these lymphomas.They discovered that all the tumors expressed FAS at very high levels.

FAS is common in the rest of the body, especially the liver, but the normal brain appears to be free ofFAS. Caligiuri said that finding FAS in the brain tumors was an advantage. The blood-brain barriergenerally prohibits the passage of compounds from the brain into the circulatory system.

“The brain is a chemotherapy sanctuary. This means we may be able to administer anti-FAS medicineswithin the brain that could stimulate the brain tumors to self-destruct, without harming normal brain orwithout traveling to other parts of the body that normally produce FAS,” he said.

To test their ideas, Caligiuri and Baiocchi turned to laboratory animals known as SCID (severecombined immune deficient) mice. These mice lack functional immune systems of their own. Because ofthat, researchers can put normal human cells inside the animals. After about three months, the animalsdevelop actual human lymphomas with the Epstein-Barr virus that strikingly resemble the brainlymphomas seen in some patients with AIDS. In the mice, however, the tumors appear in the lymphnodes. In humans, the lymphomas appear in the brain.

The researchers were then able to use anti-FAS compounds to trigger FAS which begin killing thehuman tumor that had developed in the SCID mouse.

Baiocchi and Caligiuri next examined three fresh brain tumors from patients with AIDS and PCNSL andwere also able to show that when the tumors received anti-FAS therapy, those tumor cells died.Furthermore, the cell death begun by the anti-FAS treatment was improved by adding radiation.Currently, radiation is the only standard treatment available for PCNSL tumors. The researchers sawimproved tumor cell death when the immune stimulant interleukin 2 was used.

The next step, Caligiuri said, is to grow these same tumors in the brains of rats that have deficientimmune systems, and then test if the animals’ blood-brain barriers isolate the treatment and protect theanimals’ other organs.

“Our dream would be to give the brain gene therapy which would cause it to express what’s called FASligand, an anti-FAS molecule that binds to FAS and triggers specific cell death,” Caligiuri said, which inturn would have the possibility of destroying existing tumors.

The research is supported by a grant from the National Cancer Institute.

Baiocchi and Caligiuri began this work while at Roswell Park Cancer Institute in Buffalo, NY, butcompleted their work at Ohio State. Working with them there were Vijay P. Khatri, Matthew J.Lindemann, Mary E. Ross, Anthony J. Caprio, Thomas V. Caprio, Robert Fenstermaker and Zale P.Bernstein, all from Roswell Park. Guiliana Papoff and Giovina Ruberti, both researchers at the Instituteof Cell Biology in Rome, Italy, were part of the research team.

#


Story Source:

The above story is based on materials provided by Ohio State University. Note: Materials may be edited for content and length.


Cite This Page:

Ohio State University. "Possible New Approach To Brain Tumors In AIDS Patients." ScienceDaily. ScienceDaily, 1 September 1997. <www.sciencedaily.com/releases/1997/09/970901073315.htm>.
Ohio State University. (1997, September 1). Possible New Approach To Brain Tumors In AIDS Patients. ScienceDaily. Retrieved July 31, 2014 from www.sciencedaily.com/releases/1997/09/970901073315.htm
Ohio State University. "Possible New Approach To Brain Tumors In AIDS Patients." ScienceDaily. www.sciencedaily.com/releases/1997/09/970901073315.htm (accessed July 31, 2014).

Share This




More Health & Medicine News

Thursday, July 31, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Dangerous Bacteria Kills One in Florida

Dangerous Bacteria Kills One in Florida

AP (July 31, 2014) Sarasota County, Florida health officials have issued a warning against eating raw oysters and exposing open wounds to coastal and inland waters after a dangerous bacteria killed one person and made another sick. (July 31) Video provided by AP
Powered by NewsLook.com
Health Insurers' Profits Slide

Health Insurers' Profits Slide

Reuters - Business Video Online (July 30, 2014) Obamacare-related costs were said to be behind the profit plunge at Wellpoint and Humana, but Wellpoint sees the new exchanges boosting its earnings for the full year. Fred Katayama reports. Video provided by Reuters
Powered by NewsLook.com
Peace Corps Pulls Workers From W. Africa Over Ebola Fears

Peace Corps Pulls Workers From W. Africa Over Ebola Fears

Newsy (July 30, 2014) The Peace Corps is one of several U.S.-based organizations to pull workers out of West Africa because of the Ebola outbreak. Video provided by Newsy
Powered by NewsLook.com
Weather Kills 2K A Year, But Storms Aren't The Main Offender

Weather Kills 2K A Year, But Storms Aren't The Main Offender

Newsy (July 30, 2014) Health officials say 2,000 deaths occur each year in the U.S. due to weather, but it's excessive heat and cold that claim the most lives. Video provided by Newsy
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

    Environment News

    Technology News



      Save/Print:
      Share:

      Free Subscriptions


      Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

      Get Social & Mobile


      Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

      Have Feedback?


      Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
      Mobile: iPhone Android Web
      Follow: Facebook Twitter Google+
      Subscribe: RSS Feeds Email Newsletters
      Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins